Catalyst Pharmaceutical Partners Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
Catalyst Defends Firdapse Pricing In Response Letter To Bernie Sanders
Article By: The Fly
Thursday, February 21, 2019 4:08 PM EST
The pharmaceutical company takes exception to Sanders' complaint.
In this article: CPRX
Read
2 Hot Biotechs With Major FDA Catalysts
Article By: TipRanks
Wednesday, October 24, 2018 4:58 AM EST
Biotech stocks can soar or plunge depending on FDA decisions. There’s no doubt that buying ahead of PDUFA dates is a risky call.
In this article: ACRX, CPRX Also: TXMD, OCUL
Read
Why You Should Pass On Investing In This $3.00 Drug Stock
Article By: Bret Jensen
Tuesday, November 3, 2015 12:19 PM EST
I dived in deeper myself before making any decision to recommend this company as a holding. Catalyst Pharmaceuticals (CPRX) goes for just over $3.00 a share and has been getting some positive attention from analysts recently.
In this article: VRX, CPRX
Read
Sell Signals - NPTN OSN UUU HF CPRX
Article By: Jim Van Meerten
Thursday, August 13, 2015 8:15 PM EST
This week I deleted the following stocks for negative price momentum: Neophotonics, Ossen Innovation, Universal Security Instruments, HFF and Catalyst Pharmaceuticals.
In this article: HF, NPTN, UUU, OSN, CPRX
Read
Healthcare Review: CPRX, CANF, ACST, NWBO, ACT
Article By: BioMedReports
Wednesday, October 1, 2014 3:35 AM EST
The Dow Jones Industrial Average rose 37 points, or 0.2%, to 17108. The S&P 500 added four points, or 0.2%, to 1982, and the Nasdaq Composite Index rose six points, or 0.1%, to 4512.
In this article: NWBO, ACST, CPRX, ACT, CANF
Read

PARTNER HEADLINES

Latest Tweets for $CPRX

No tweets yet!